CocoLoco
FN #5
WSJ: The Million-Dollar Cancer Treatment: Who Will Pay?
I posted about these treatments a few years ago when they were in their clinical phases. Now they are finally getting FDA approval and hitting the mainstream. The WSJ is suggesting that the treatments are going to cause a balloon in healthcare costs. I'd like to suggest otherwise. Much of the post procedure cost will be reduced as the understanding and application of the treatments expand. As more knowledge is gained about the treatments further refinements will be made to bring costs down. Also, many of the steps in the process are the same so economies of scale will be available. Finally, the treatments have proven to eradicate all signs of the targeted cancer. If this continue to hold true then the treatment is a one-time thing rather than a series of surgery, chemo, and other treatments such as radiation. It's one and done. The article didn't do any comparison of cost with current treatments and outcomes.
What says the BRAFs?
I posted about these treatments a few years ago when they were in their clinical phases. Now they are finally getting FDA approval and hitting the mainstream. The WSJ is suggesting that the treatments are going to cause a balloon in healthcare costs. I'd like to suggest otherwise. Much of the post procedure cost will be reduced as the understanding and application of the treatments expand. As more knowledge is gained about the treatments further refinements will be made to bring costs down. Also, many of the steps in the process are the same so economies of scale will be available. Finally, the treatments have proven to eradicate all signs of the targeted cancer. If this continue to hold true then the treatment is a one-time thing rather than a series of surgery, chemo, and other treatments such as radiation. It's one and done. The article didn't do any comparison of cost with current treatments and outcomes.
What says the BRAFs?
Last edited: